212 related articles for article (PubMed ID: 28285462)
1. 2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.
Santos CMM; Ribeiro D; Silva AMS; Fernandes E
Inflammation; 2017 Jun; 40(3):956-964. PubMed ID: 28285462
[TBL] [Abstract][Full Text] [Related]
2. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways.
Gomes A; Fernandes E; Silva AM; Pinto DC; Santos CM; Cavaleiro JA; Lima JL
Biochem Pharmacol; 2009 Jul; 78(2):171-7. PubMed ID: 19464432
[TBL] [Abstract][Full Text] [Related]
4. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
[TBL] [Abstract][Full Text] [Related]
5. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade.
Sala A; Proschak E; Steinhilber D; Rovati GE
Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of 5-lipoxygenase/cyclooxygenase by a reconstituted homeopathic remedy; possible explanation for clinical efficacy and favourable gastrointestinal tolerability.
Jäggi R; Würgler U; Grandjean F; Weiser M
Inflamm Res; 2004 Apr; 53(4):150-7. PubMed ID: 15060721
[TBL] [Abstract][Full Text] [Related]
7. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
8. Frontline Science: Reprogramming COX-2, 5-LOX, and CYP4A-mediated arachidonic acid metabolism in macrophages by salidroside alleviates gouty arthritis.
Liu Y; Tang H; Liu X; Chen H; Feng N; Zhang J; Wang C; Qiu M; Yang J; Zhou X
J Leukoc Biol; 2019 Jan; 105(1):11-24. PubMed ID: 30265377
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory effects of Yunnan Baiyao are involved in regulation of the phospholipase A2/arachidonic acid metabolites pathways in acute inflammation rat model.
Ren X; Zhang M; Chen L; Zhang W; Huang Y; Luo H; Li L; He H
Mol Med Rep; 2017 Oct; 16(4):4045-4053. PubMed ID: 28765972
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
Sud'ina GF; Pushkareva MA; Shephard P; Klein T
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
[TBL] [Abstract][Full Text] [Related]
11. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
[TBL] [Abstract][Full Text] [Related]
13. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils.
Hsu MF; Lin CN; Lu MC; Wang JP
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):507-15. PubMed ID: 15083266
[TBL] [Abstract][Full Text] [Related]
15. Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils.
St-Onge M; Flamand N; Biarc J; Picard S; Bouchard L; Dussault AA; Laflamme C; James MJ; Caughey GE; Cleland LG; Borgeat P; Pouliot M
Biochim Biophys Acta; 2007 Sep; 1771(9):1235-45. PubMed ID: 17643350
[TBL] [Abstract][Full Text] [Related]
16. Dual acting anti-inflammatory drugs.
Leone S; Ottani A; Bertolini A
Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
[TBL] [Abstract][Full Text] [Related]
17. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
19. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
